Schuller DE - Search Results

1

Evaluation of the combination of docetaxel/carboplatin in patients with metastatic or recurrent squamous cell carcinoma of the head and neck (SCCHN): a Southwest Oncology Group Phase II study.

Samlowski WE, Moon J, Kuebler JP, Nichols CR, Gandara DR, Ozer H, Williamson SK, Atkins JN, Schuller DE, Ensley JF. Samlowski WE, et al. Among authors: schuller de. Cancer Invest. 2007 Apr-May;25(3):182-8. doi: 10.1080/07357900701209061. Cancer Invest. 2007. PMID: 17530488 Clinical Trial.

2

Evaluation of Tomudex in patients with recurrent or metastatic squamous cell carcinoma of the head and neck: a Southwest Oncology Group study.

Samlowski WE, Lew D, Kuebler PJ, Kolodziej MA, Medina JE, Mangan KF, Moore DF Jr, Schuller DE, Ensley JF. Samlowski WE, et al. Among authors: schuller de. Invest New Drugs. 1998-1999;16(3):271-4. doi: 10.1023/a:1006178808095. Invest New Drugs. 1998. PMID: 10360608 Clinical Trial.

3

Evaluation of gemcitabine in patients with recurrent or metastatic squamous cell carcinoma of the head and neck: a Southwest Oncology Group phase II study.

Samlowski WE, Gundacker H, Kuebler JP, Giguere JK, Mills GM, Schuller DE, Ensley JF. Samlowski WE, et al. Among authors: schuller de. Invest New Drugs. 2001;19(4):311-5. doi: 10.1023/a:1010657609609. Invest New Drugs. 2001. PMID: 11561690 Clinical Trial.

4

Evaluation of 96-hour infusion fluorouracil plus cisplatin in combination with alpha interferon for patients with advanced squamous cell carcinoma of the head and neck: a Southwest Oncology Group study.

Hussain M, Benedetti J, Smith RE, Rodriguez GI, Schuller D, Ensley J. Hussain M, et al. Cancer. 1995 Oct 1;76(7):1233-7. doi: 10.1002/1097-0142(19951001)76:7<1233::aid-cncr2820760721>3.0.co;2-q. Cancer. 1995. PMID: 8630903 Clinical Trial.

5

Evaluation of topotecan in patients with recurrent for metastatic squamous cell carcinoma of the head and neck. A phase II Southwest Oncology Group study.

Smith RE, Lew D, Rodriguez GI, Taylor SA, Schuller D, Ensley JF. Smith RE, et al. Invest New Drugs. 1996;14(4):403-7. doi: 10.1007/BF00180818. Invest New Drugs. 1996. PMID: 9157077 Clinical Trial.

6

Phase II study of edatrexate in advanced head and neck cancer. A Southwest Oncology Group study.

Kuebler JP, Benedetti J, Schuller DE, Ensley J, Grunberg SM, Muirhead MJ, Richert-Boe KE, Marshall ME. Kuebler JP, et al. Among authors: schuller de. Invest New Drugs. 1994;12(4):341-4. doi: 10.1007/BF00873052. Invest New Drugs. 1994. PMID: 7775138 Clinical Trial.

7

Randomized comparison of cisplatin plus fluorouracil and carboplatin plus fluorouracil versus methotrexate in advanced squamous-cell carcinoma of the head and neck: a Southwest Oncology Group study.

Forastiere AA, Metch B, Schuller DE, Ensley JF, Hutchins LF, Triozzi P, Kish JA, McClure S, VonFeldt E, Williamson SK, et al. Forastiere AA, et al. Among authors: schuller de. J Clin Oncol. 1992 Aug;10(8):1245-51. doi: 10.1200/JCO.1992.10.8.1245. J Clin Oncol. 1992. PMID: 1634913 Clinical Trial.

8

Phase II study of fazarabine in advanced head and neck cancer. A Southwest Oncology Group study.

Kuebler JP, Metch B, Schuller DE, Keppen M, Hynes HE. Kuebler JP, et al. Among authors: schuller de. Invest New Drugs. 1991 Nov;9(4):373-4. doi: 10.1007/BF00183585. Invest New Drugs. 1991. PMID: 1725172 Clinical Trial. No abstract available.

9

An intergroup phase III comparison of standard radiation therapy and two schedules of concurrent chemoradiotherapy in patients with unresectable squamous cell head and neck cancer.

Adelstein DJ, Li Y, Adams GL, Wagner H Jr, Kish JA, Ensley JF, Schuller DE, Forastiere AA. Adelstein DJ, et al. Among authors: schuller de. J Clin Oncol. 2003 Jan 1;21(1):92-8. doi: 10.1200/JCO.2003.01.008. J Clin Oncol. 2003. PMID: 12506176 Clinical Trial.

10

Organ preservation for advanced resectable cancer of the base of tongue and hypopharynx: a Southwest Oncology Group Trial.

Urba SG, Moon J, Giri PG, Adelstein DJ, Hanna E, Yoo GH, Leblanc M, Ensley JF, Schuller DE. Urba SG, et al. Among authors: schuller de. J Clin Oncol. 2005 Jan 1;23(1):88-95. doi: 10.1200/JCO.2005.04.017. J Clin Oncol. 2005. PMID: 15625363 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

260 results

Search Page

Filters